Porcine Pili Shield (Canada)

This page contains information on Porcine Pili Shield for veterinary use.
The information provided typically includes the following:

Porcine Pili Shield Indications
Warnings and cautions for Porcine Pili Shield
Direction and dosage information for Porcine Pili Shield

Porcine Pili Shield

This treatment applies to the following species:

Swine

Company: Elanco

Escherichia Coli Bacterin

For Use in Animals Only

Porcine Pili Shield Indications

For use in healthy pregnant swine as an aid in the control of disease in piglets caused by K88, K99, 987P, and F41 piliated Escherichia coli.

ADJUVANT: Aluminum hydroxide.

Directions For Use

Shake well before using. Administer 2 mL intramuscularly 5 and 2 weeks prior to farrowing. Revaccinate prior to each subsequent farrowing.

Precautions

Store out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Do not mix with other products, except as specified on the label. Use entire contents when first opened. In case of human exposure, contact a physician. Do not vaccinate within 21 days prior to slaughter. It is essential that newborn pigs receive colostrum from the vaccinated dam. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

Manufactured by Elanco US Inc., Fort Dodge, IA, USA.

USDA Vet. Biologics Est. Lic. No. 196.

For Elanco Canada Limited, Mississauga, Ontario, Canada L5N 0C9; 1-800-265-5475.

Porcine Pili Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

50 Doses

100 mL

YL103592X

CPN: 1231081.7

ELANCO CANADA LIMITED
1919 MINNESOTA COURT, SUITE 401, MISSISSAUGA, ON, L5N 0C9

Customer Service:		800-265-5475
Fax:		519-821-7831
Website:		www.elanco.ca
Email:		elancocanadacustomerservice@elancoah.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.